Log In
Or login using:
Sign Up
Or sign up using:
Forgotten Password
Upgrade to a paid membership and never see an advert again!
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock CANCER FOCUS NORTHERN IRELAND's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteCANCER FOCUS NORTHERN IRELAND
MONTGOMERY HOUSE - 6TH FLOOR, 29-33 MONTGOMERY STREET, BELFAST, BT1 4NX
Unlock Report
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
CANCER FOCUS NORTHERN IRELAND
Private Limited by guarantee without Share Capital Exempt from using Limited
Active - Accounts Filed
20 February 2004
86900 Other human health activities - Other human health activities
Available to 22 Oct 2025. Next accounts due by 31 Dec 2026
Is CANCER FOCUS NORTHERN IRELAND in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mr William McCullins | Director | ||
| Dr Irene Paula O'Hare | Director | ||
| Mrs Margaret Anne Brown | Director | ||
| Mr Richard Spratt | Company Secretary | ||
| Mr Donald Harte | Director | ||
| Mrs Caroline Murdoch | Director | ||
| Dr Helen Jane Reid | Director | ||
| Dr Bernadette Cullen | Director | ||
| Dr Andrew Edward William Gilliland | Director | ||
| Mrs Violet Newton Spence | Director | ||
| Professor Mark Philip Lawler | Director | ||
| Mr John Boyd Carson | Director |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
0
Total Satisfied
2
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Northern Bank Limited | SATISFIED | |||
| Mortgage Or Charge | National Lottery Charities Board/ New Oppertunitie | SATISFIED |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £709,549.00 | £1,057,037.00 | £1,345,054.00 | £1,345,209.00 | £1,178,828.00 |
| Net Worth | £3,367,658.00 | £3,325,679.00 | £3,249,983.00 | £3,185,415.00 | £2,890,871.00 |
| Total Current Liabilities | £368,666.00 | £189,593.00 | £268,944.00 | £336,533.00 | £484,707.00 |
| Total Current Assets | £1,209,359.00 | £2,469,888.00 | £2,725,781.00 | £1,470,922.00 | £1,339,630.00 |
Frequently Asked Questions about CANCER FOCUS NORTHERN IRELAND
Detailed answers about CANCER FOCUS NORTHERN IRELAND, including incorporation, status, business activity, and accounts information.
When was CANCER FOCUS NORTHERN IRELAND founded?
CANCER FOCUS NORTHERN IRELAND was officially incorporated on 20 February 2004 and is registered under company number NI049781. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CANCER FOCUS NORTHERN IRELAND?
Private Limited by guarantee without Share Capital Exempt from using Limited. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CANCER FOCUS NORTHERN IRELAND?
CANCER FOCUS NORTHERN IRELAND's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CANCER FOCUS NORTHERN IRELAND do?
CANCER FOCUS NORTHERN IRELAND operates in the following sector: 86900 Other human health activities - Other human health activities . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is CANCER FOCUS NORTHERN IRELAND's registered address?
The registered office address of CANCER FOCUS NORTHERN IRELAND is 33, Montgomery Street, Belfast, Northern Ireland, BT1 4NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is CANCER FOCUS NORTHERN IRELAND financially stable?
Based on the latest accounts up to 22 Oct 2025, CANCER FOCUS NORTHERN IRELAND has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 31 Dec 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.